School of Medicine, Autonomous University of Barcelona, Barcelona, Spain; Human Neuropsychopharmacology Research Group, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Pharmacokinetic and Pharmacodynamic Modelling and Simulation, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Centre d'Investigació de Medicaments, Servei de Farmacologia Clínica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Spain; Department of Pharmacology and Therapeutics, Autonomous University of Barcelona, Barcelona, Spain; Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Research Center for the Study of Psychointegrator Plants, Visionary Art and Consciousness, Florianópolis, Santa Catarina, Brazil; Department of Neuroscience and Behavior, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil and National Institute for Translational Medicine, Ribeirão Preto, Brazil; Brain Institute/Hospital Universitario Onofre Lopes, Natal, Brazil; The Beckley Foundation, Beckley Park, Oxford, United Kingdom; Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Skip Bertman Drive at River Road, Baton Rouge, Louisiana; Department of Clinical and Health Psychology, School of Psychology, Autonomous University of Barcelona, Barcelona, Spain.
Int J Neuropsychopharmacol. 2017 Sep 1;20(9):698-711. doi: 10.1093/ijnp/pyx036.
Ayahuasca is a plant tea containing the psychedelic 5-HT2A agonist N,N-dimethyltryptamine and harmala monoamine-oxidase inhibitors. Acute administration leads to neurophysiological modifications in brain regions of the default mode network, purportedly through a glutamatergic mechanism. Post-acutely, ayahuasca potentiates mindfulness capacities in volunteers and induces rapid and sustained antidepressant effects in treatment-resistant patients. However, the mechanisms underlying these fast and maintained effects are poorly understood. Here, we investigated in an open-label uncontrolled study in 16 healthy volunteers ayahuasca-induced post-acute neurometabolic and connectivity modifications and their association with mindfulness measures.
Using 1H-magnetic resonance spectroscopy and functional connectivity, we compared baseline and post-acute neurometabolites and seed-to-voxel connectivity in the posterior and anterior cingulate cortex after a single ayahuasca dose.
Magnetic resonance spectroscopy showed post-acute reductions in glutamate+glutamine, creatine, and N-acetylaspartate+N-acetylaspartylglutamate in the posterior cingulate cortex. Connectivity was increased between the posterior cingulate cortex and the anterior cingulate cortex, and between the anterior cingulate cortex and limbic structures in the right medial temporal lobe. Glutamate+glutamine reductions correlated with increases in the "nonjudging" subscale of the Five Facets Mindfulness Questionnaire. Increased anterior cingulate cortex-medial temporal lobe connectivity correlated with increased scores on the self-compassion questionnaire. Post-acute neural changes predicted sustained elevations in nonjudging 2 months later.
These results support the involvement of glutamate neurotransmission in the effects of psychedelics in humans. They further suggest that neurometabolic changes in the posterior cingulate cortex, a key region within the default mode network, and increased connectivity between the anterior cingulate cortex and medial temporal lobe structures involved in emotion and memory potentially underlie the post-acute psychological effects of ayahuasca.
阿育吠陀是一种植物茶,含有迷幻 5-HT2A 激动剂 N,N-二甲基色胺和哈玛拉单胺氧化酶抑制剂。急性给药会导致默认模式网络中脑区的神经生理改变,据称这是通过谷氨酸能机制实现的。在急性后,阿育吠陀能增强志愿者的正念能力,并在治疗抵抗的患者中诱导快速和持续的抗抑郁作用。然而,这些快速和持续的作用的机制还知之甚少。在这里,我们在 16 名健康志愿者的开放标签非对照研究中,研究了阿育吠陀诱导的急性后神经代谢和连接改变及其与正念测量的关系。
我们使用 1H 磁共振波谱和功能连接,比较了单次阿育吠陀剂量后后扣带回皮质和前扣带回皮质的基线和急性后神经代谢物和种子到体素连接。
磁共振波谱显示,后扣带回皮质的谷氨酸+谷氨酰胺、肌酸和 N-乙酰天冬氨酸+N-乙酰天冬氨酸谷氨酸在急性后减少。后扣带皮质与前扣带皮质之间以及前扣带皮质与右侧内侧颞叶的边缘结构之间的连接增加。谷氨酸+谷氨酰胺减少与五因素正念问卷的“非评判”子量表的增加相关。前扣带皮质-内侧颞叶连接的增加与自我同情问卷得分的增加相关。急性后神经变化预测 2 个月后非评判的持续升高。
这些结果支持谷氨酸能神经传递在人类迷幻剂作用中的参与。它们进一步表明,后扣带皮质内默认模式网络的关键区域的神经代谢变化以及前扣带皮质和内侧颞叶结构之间的连接增加,可能是阿育吠陀急性后心理效应的基础。